Lu, D., Girish, S., Gao, Y., Wang, B., Yi, J., Guardino, E., . . . Jin, J. Y. (2014). Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody–drug conjugate, in patients with HER2-positive metastatic breast cancer: Clinical implications of the effect of covariates. Springer Berlin Heidelberg.
Styl ChicagoLu, Dan, et al. Population Pharmacokinetics of Trastuzumab Emtansine (T-DM1), a HER2-targeted Antibody–drug Conjugate, in Patients With HER2-positive Metastatic Breast Cancer: Clinical Implications of the Effect of Covariates. Springer Berlin Heidelberg, 2014.
Citace podle MLALu, Dan, et al. Population Pharmacokinetics of Trastuzumab Emtansine (T-DM1), a HER2-targeted Antibody–drug Conjugate, in Patients With HER2-positive Metastatic Breast Cancer: Clinical Implications of the Effect of Covariates. Springer Berlin Heidelberg, 2014.